263 related articles for article (PubMed ID: 26676363)
1. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
Li J; Bian EB; He XJ; Ma CC; Zong G; Wang HL; Zhao B
Int J Oncol; 2016 Feb; 48(2):723-33. PubMed ID: 26676363
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA MEG3 Interacts with p53 Protein and Regulates Partial p53 Target Genes in Hepatoma Cells.
Zhu J; Liu S; Ye F; Shen Y; Tie Y; Zhu J; Wei L; Jin Y; Fu H; Wu Y; Zheng X
PLoS One; 2015; 10(10):e0139790. PubMed ID: 26444285
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21.
Li Z; Yang L; Liu X; Nie Z; Luo J
Biomed Pharmacother; 2018 Aug; 104():181-192. PubMed ID: 29772439
[TBL] [Abstract][Full Text] [Related]
5. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer.
Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W
Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway.
Zhang L; Liang X; Li Y
Oncol Rep; 2017 Oct; 38(4):2408-2416. PubMed ID: 28791407
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer.
Zhang J; Lin Z; Gao Y; Yao T
J Exp Clin Cancer Res; 2017 Jan; 36(1):5. PubMed ID: 28057015
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of long non-coding RNA MEG3 in nasopharyngeal carcinoma.
Chak WP; Lung RW; Tong JH; Chan SY; Lun SW; Tsao SW; Lo KW; To KF
Mol Carcinog; 2017 Mar; 56(3):1041-1054. PubMed ID: 27597634
[TBL] [Abstract][Full Text] [Related]
9. Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway.
Kruer TL; Dougherty SM; Reynolds L; Long E; de Silva T; Lockwood WW; Clem BF
PLoS One; 2016; 11(11):e0166363. PubMed ID: 27832204
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma.
Gao Y; Huang P; Zhang J
J Transl Med; 2017 Dec; 15(1):268. PubMed ID: 29287592
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation.
Wang P; Ren Z; Sun P
J Cell Biochem; 2012 Jun; 113(6):1868-74. PubMed ID: 22234798
[TBL] [Abstract][Full Text] [Related]
12. SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.
Han F; Liu W; Jiang X; Shi X; Yin L; Ao L; Cui Z; Li Y; Huang C; Cao J; Liu J
Oncogene; 2015 Aug; 34(33):4391-402. PubMed ID: 25435374
[TBL] [Abstract][Full Text] [Related]
13. The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma.
Zhuo H; Tang J; Lin Z; Jiang R; Zhang X; Ji J; Wang P; Sun B
Mol Carcinog; 2016 Feb; 55(2):209-19. PubMed ID: 25641194
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
Cheng JC; Auersperg N; Leung PC
Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
Modali SD; Parekh VI; Kebebew E; Agarwal SK
Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
[TBL] [Abstract][Full Text] [Related]
16. DNMT1-mediated demethylation of lncRNA MEG3 promoter suppressed breast cancer progression by repressing Notch1 signaling pathway.
Pan T; Ding H; Jin L; Zhang S; Wu D; Pan W; Dong M; Ma X; Chen Z
Cell Cycle; 2022 Nov; 21(21):2323-2337. PubMed ID: 35822955
[TBL] [Abstract][Full Text] [Related]
17. A novel interplay between HOTAIR and DNA methylation in osteosarcoma cells indicates a new therapeutic strategy.
Li X; Lu H; Fan G; He M; Sun Y; Xu K; Shi F
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2189-2200. PubMed ID: 28730284
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma.
Guo W; Dong Z; Liu S; Qiao Y; Kuang G; Guo Y; Shen S; Liang J
Mol Carcinog; 2017 Aug; 56(8):1924-1934. PubMed ID: 28345805
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA MEG3 activation of p53 mediates ischemic neuronal death in stroke.
Yan H; Yuan J; Gao L; Rao J; Hu J
Neuroscience; 2016 Nov; 337():191-199. PubMed ID: 27651151
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of adenosine-mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells.
Liu LX; Deng W; Zhou XT; Chen RP; Xiang MQ; Guo YT; Pu ZJ; Li R; Wang GF; Wu LF
Int J Oncol; 2016 Jan; 48(1):421-9. PubMed ID: 26647875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
